Current developments in pediatric liver transplantation

World Journal of Hepatology

Volumn 7, Issue 11, 2015, Pages 1509-1520

  Hackl, Christina ^a   Schlitt, Hans J ^a   Melter, Michael ^a   Knoppke, Birgit ^a   Loss, Martin ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Biliary atresia; Deceased organ donation; Living donor liver transplantation; Pediatric liver transplantation; Split liver transplantation

Indexed keywords

EID: 84930832578     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i11.1509     Document Type: Review

References (111)

1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659-676 [PMID: 14100514]
2. Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB, Blanchard H, Martin AJ, Porter KA. Orthotopic homotransplantation of the human liver. Ann Surg 1968; 168:392-415 [PMID: 4877589]
3. Starzl TE, Koep LJ, Schröter GP, Halgrimson CG, Porter KA, Weil R. Liver replacement for pediatric patients. Pediatrics 1979; 63: 825-829 [PMID: 377201]
4. Pichlmayr R, Brölsch C, Wonigeit K, Neuhaus P, Siegismund S, Schmidt FW, Burdelski M. Experiences with liver transplantation in Hannover. Hepatology 1984; 4: 56S-60S [PMID: 6319265]
5. Yazigi NA. Long term outcomes after pediatric liver transplantation. Pediatr Gastroenterol Hepatol Nutr 2013; 16: 207-218 [PMID: 24511516 DOI: 10.5223/pghn.2013.16.4.207]
6. Abramson O, Rosenthal P. Current status of pediatric liver transplantation. Clin Liver Dis 2000; 4: 533-552 [PMID: 11232160]
7. Melter M, Grothues D, Knoppke B. Pädiatrische Lebertransplantation. Monatsschr Kinderheilkd 2012; 160: 343-357 [DOI:10.1007/s00112-011-2561-9]
8. Fine RN. Growth following solid-organ transplantation. Pediatr Transplant 2002; 6: 47-52 [PMID: 11906643]
9. Moukarzel AA, Najm I, Vargas J, McDiarmid SV, Busuttil RW, Ament ME. Effect of nutritional status on outcome of orthotopic liver transplantation in pediatric patients. Transplant Proc 1990; 22: 1560-1563 [PMID: 2389401]
10. Moukarzel AA, Najm I, Vargas J, McDiarmid SV, Busuttil RW, Ament ME. Prediction of long-term linear growth following liver transplantation. Transplant Proc 1990; 22: 1558-1559 [PMID:2389400]
11. Rodeck B, Melter M, Kardorff R, Hoyer PF, Ringe B, Burdelski M, Oldhafer KJ, Pichlmayr R, Brodehl J. Liver transplantation in children with chronic end stage liver disease: factors influencing survival after transplantation. Transplantation 1996; 62: 1071-1076 [PMID: 8900304]
12. Stewart SM, Uauy R, Waller DA, Kennard BD, Benser M, Andrews WS. Mental and motor development, social competence, and growth one year after successful pediatric liver transplantation. J Pediatr 1989; 114: 574-581 [PMID: 2647947]
13. Wayman KI, Cox KL, Esquivel CO. Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation. J Pediatr 1997; 131: 894-898 [PMID:9427896]
14. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871 [PMID: 10733541 DOI: 10.1053/he.2000.5852]
15. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903 [PMID: 15158328 DOI: 10.1016/j.jhep.2004.02.010]
16. Rodeck B, Melter M, Kardorff R, Hoyer PF, Ringe B, Burdelski M, Oldhafer KJ, Pichlmayr R, Brodehl J. Liver transplantation in children with chronic end stage liver disease: factors influencing survival after transplantation. Transplantation 1996; 62: 1071-1076 [PMID: 8900304]
17. Freeman RB, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, Merion R, Wolfe R, Turcotte J, Teperman L; UNOS/ OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-858 [PMID:12200791 DOI: 10.1053/jlts.2002.35927]
18. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, Kim WR. MELD and PELD:application of survival models to liver allocation. Liver Transpl 2001; 7: 567-580 [PMID: 11460223 DOI: 10.1053/jlts.2001.25879]
19. McDiarmid SV, Anand R, Lindblad AS; Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002; 74: 173-181 [PMID:12151728]
20. McDiarmid SV. New liver allocation policies and their potential effect on pediatric patients awaiting liver transplantation. Pediatr Transplant 2002; 6: 180-186 [PMID: 12100501]
21. Eurotransplant International Foundation. EAR 2013. Available from: http://www.eurotransplant.org/cms/index.php?page=annual_ reports
22. McDiarmid SV, Merion RM, Dykstra DM, Harper AM. Selection of pediatric candidates under the PELD system. Liver Transplantation 2004; 10: S23-S30 [DOI: 10.1002/lt.20272]
23. Lee SG, Moon DB. Living donor liver transplantation for hepatocellular carcinoma. Recent Results Cancer Res 2013; 190:165-179 [PMID: 22941020 DOI: 10.1007/978-3-642-16037-0_11]
24. Moon DB, Lee SG, Hwang S, Kim KH, Ahn CS, Ha TY, Song GW, Jung DH, Park GC, Namkoong JM, Park HW, Park YH, Park CS. More than 300 consecutive living donor liver transplants a year at a single center. Transplant Proc 2013; 45: 1942-1947 [PMID:23769079]
25. Song GW, Lee SG, Hwang S, Ahn CS, Moon DB, Kim KH, Ha TY, Jung DH, Park GC, Namgung JM, Park CS, Park HW, Park YH. Successful experiences of ABO-incompatible adult living donor liver transplantation in a single institute: no immunological failure in 10 consecutive cases. Transplant Proc 2013; 45: 272-275 [PMID: 23375314 DOI: 10.1016/j.transproceed]
26. Broelsch CE, Emond JC, Thistlethwaite JR, Whitington PF, Zucker AR, Baker AL, Aran PF, Rouch DA, Lichtor JL. Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg 1988; 208: 410-420 [PMID:3052326]
27. Broelsch CE, Emond JC, Thistlethwaite JR, Rouch DA, Whitington PF, Lichtor JL. Liver transplantation with reducedsize donor organs. Transplantation 1988; 45: 519-524 [PMID:3279573]
28. Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. [Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir 1988; 373:127-130 [PMID: 3287073]
29. Couinaud C. [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver]. Presse Med 1954; 62:709-712 [PMID: 13177441]
30. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 1999; 16: 459-467 [PMID: 10805544]
31. Busuttil RW, Goss JA. Split liver transplantation. Ann Surg 1999; 229: 313-321 [PMID: 10077042]
32. Kanazawa H, Sakamoto S, Fukuda A, Uchida H, Hamano I, Shigeta T, Kobayashi M, Karaki C, Tanaka H, Kasahara M. Livingdonor liver transplantation with hyperreduced left lateral segment grafts: a single-center experience. Transplantation 2013; 95:750-754 [PMID: 23503505 DOI: 10.1097/TP.0b013e31827a93b4]
33. Caso Maestro O, Abradelo de Usera M, Justo Alonso I, Calvo Pulido J, Manrique Municio A, Cambra Molero F, García Sesma A, Loinaz Segurola C, Moreno González E, Jiménez Romero C. Porcine acellular dermal matrix for delayed abdominal wall closure after pediatric liver transplantation. Pediatr Transplant 2014; 18:594-598 [PMID: 25039398 DOI: 10.1111/petr.12319]
34. Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg 1991; 15:660-665; discussion 665-666 [PMID: 1949867]
35. Faraj W, Dar F, Bartlett A, Melendez HV, Marangoni G, Mukherji D, Vergani GM, Dhawan A, Heaton N, Rela M. Auxiliary liver transplantation for acute liver failure in children. Ann Surg 2010; 251: 351-356 [PMID: 20054274 DOI: 10.1097/SLA.0b013e3181b dfef6]
36. Shanmugam NP, Dhawan A. Selection criteria for liver transplantation in paediatric acute liver failure: the saga continues. Pediatr Transplant 2011; 15: 5-6 [PMID: 21241436 DOI: 10.1111/ j.1399-3046.2010.01457.x]
37. Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D' Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009; 9: 2004-2011 [PMID: 19624569 DOI: 10.1111/ j.1600-6143.2009.02739.x]
38. Snoeijs MG, Wind T, van Heurn E. Protocols for uncontrolled donation after circulatory death. Lancet 2012; 380: 974-975; author reply 975 [PMID: 22981110 DOI: 10.1016/S0140-6736(12)61533-5]
39. Bernat JL, Capron AM, Bleck TP, Blosser S, Bratton SL, Childress JF, DeVita MA, Fulda GJ, Gries CJ, Mathur M, Nakagawa TA, Rushton CH, Shemie SD, White DB. The circulatory-respiratory determination of death in organ donation. Crit Care Med 2010; 38:963-970 [PMID: 20124892 DOI: 10.1097/CCM.0b013e3181c58916]
40. WHO; Transplantation Society (TTS); Organizatión Nacional de Transplantes (url). Third WHO Global Consultation on Organ Donation and Transplantation: striving to achieve selfsufficiency, March 23-25, 2010, Madrid, Spain. Transplantation 2011; 91 Suppl 11: S27-S28 [PMID: 21633280 DOI: 10.1097/ TP.0b013e3182190b29]
41. Morrissey PE, Monaco AP. Donation after circulatory death:current practices, ongoing challenges, and potential improvements. Transplantation 2014; 97: 258-264 [PMID: 24492420 DOI:10.1097/01.TP.0000437178.48174.db]
42. Fondevila C, Hessheimer AJ, Flores E, Ruiz A, Mestres N, Calatayud D, Paredes D, Rodríguez C, Fuster J, Navasa M, Rimola A, Taurá P, García-Valdecasas JC. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant 2012; 12: 162-170 [PMID: 22070538 DOI:10.1111/j.1600-6143.2011.03834.x]
43. Waki K. UNOS Liver Registry: ten year survivals. Clin Transpl 2006: 29-39 [PMID: 18368704]
44. Dubbeld J, Hoekstra H, Farid W, Ringers J, Porte RJ, Metselaar HJ, Baranski AG, Kazemier G, van den Berg AP, van Hoek B. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg 2010; 97: 744-753 [PMID:20393979 DOI: 10.1002/bjs.7043]
45. Jay CL, Lyuksemburg V, Ladner DP, Wang E, Caicedo JC, Holl JL, Abecassis MM, Skaro AI. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg 2011; 253: 259-264 [PMID: 21245668 DOI: 10.1097/SLA.0b013e318204e658]
46. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990; 212: 368-375; discussion 375-377 [PMID: 2396888]
47. Organ Procurement and Transplantation Network. [Accessed 2014 Dec 1]. Available from: URL: http://optn.transplant.hrsa.gov/ converge/latestdata/rptData.asp
48. Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, Ichai P, Saliba F, Adam R, Castaing D, Azoulay D. Intention-totreat analysis of liver transplantation for hepatocellular carcinoma:living versus deceased donor transplantation. Hepatology 2011; 53:1570-1579 [PMID: 21520172 DOI: 10.1002/hep.24231]
49. Gondolesi GE, Roayaie S, Muñoz L, Kim-Schluger L, Schiano T, Fishbein TM, Emre S, Miller CM, Schwartz ME. Adult living donor liver transplantation for patients with hepatocellular carcinoma:extending UNOS priority criteria. Ann Surg 2004; 239: 142-149 [PMID: 14745320 DOI: 10.1097/01.sla.0000109022.32391.eb]
50. Grant RC, Sandhu L, Dixon PR, Greig PD, Grant DR, McGilvray ID. Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transplant 2013; 27: 140-147 [PMID: 23157398 DOI:10.1111/ctr.12031]
51. Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 2003; 75: S37-S40 [PMID: 12589138 DOI: 10.1097/01.TP.0000047029.02806.16]
52. Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Levy G, Greig PD, Renner EL, Grant DR. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence. Liver Transpl 2012; 18: 315-322 [PMID: 22140013 DOI: 10.1002/lt.22477]
53. Todo S, Furukawa H; Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451-459; discussion 459-461 [PMID: 15319716]
54. Saidi RF, Jabbour N, Li Y, Shah SA, Bozorgzadeh A. Is left lobe adult-to-adult living donor liver transplantation ready for widespread use? The US experience (1998-2010). HPB (Oxford) 2012; 14: 455-460 [PMID: 22672547 DOI: 10.1111/j.1477-2574.2012.00475.x]
55. Saidi RF, Markmann JF, Jabbour N, Li Y, Shah SA, Cosimi AB, Bozorgzadeh A. The faltering solid organ donor pool in the United States (2001-2010). World J Surg 2012; 36: 2909-2913 [PMID:22933050 DOI: 10.1007/s00268-012-1748-0]
56. Muzaale AD, Dagher NN, Montgomery RA, Taranto SE, McBride MA, Segev DL. Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology 2012; 142: 273-280 [PMID: 22108193 DOI: 10.1053/j. gastro.2011.11.015]
57. Roll GR, Roberts JP. Left versus right lobe liver donation. Am J Transplant 2014; 14: 251-252 [PMID: 24304562 DOI: 10.1111/ ajt.12556]
58. Roll GR, Parekh JR, Parker WF, Siegler M, Pomfret EA, Ascher NL, Roberts JP. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl 2013; 19: 472-481 [PMID:23447523 DOI: 10.1002/lt.23608]
59. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, Emond JC, Koffron AJ, Pruett TL, Olthoff KM. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008; 135: 468-476 [PMID: 18505689 DOI:10.1053/j.gastro.2008.04.018]
60. Kousoulas L, Becker T, Richter N, Emmanouilidis N, Schrem H, Barg-Hock H, Klempnauer J, Lehner F. Living donor liver transplantation: effect of the type of liver graft donation on donor mortality and morbidity. Transpl Int 2011; 24: 251-258 [PMID:21062368 DOI: 10.1111/j.1432-2277.2010.01183.x]
61. Kousoulas L, Emmanouilidis N, Klempnauer J, Lehner F. Livingdonor liver transplantation: impact on donor's health-related quality of life. Transplant Proc 2011; 43: 3584-3587 [PMID:22172809 DOI: 10.1016/j.transproceed.2011.10.038]
62. Lo CM. Complications and long-term outcome of living liver donors:a survey of 1,508 cases in five Asian centers. Transplantation 2003; 75: S12-S15 [PMID: 12589131]
63. Morioka D, Egawa H, Kasahara M, Ito T, Haga H, Takada Y, Shimada H, Tanaka K. Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases. Ann Surg 2007; 245: 315-325 [PMID: 17245187 DOI: 10.1097/01.sla.0000236600.24667.a4]
64. Umeshita K, Fujiwara K, Kiyosawa K, Makuuchi M, Satomi S, Sugimachi K, Tanaka K, Monden M; Japanese Liver Transplantation Society. Operative morbidity of living liver donors in Japan. Lancet 2003; 362: 687-690 [PMID: 12957090 DOI: 10.1016/ S0140-6736(03)14230-4]
65. Diamond IR, Fecteau A, Millis JM, Losanoff JE, Ng V, Anand R, Song C; SPLIT Research Group. Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg 2007; 246: 301-310 [PMID: 17667510 DOI: 10.1097/SLA.0b013e3180caa415]
66. Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant 2007; 7: 2165-2171 [PMID: 17608834 DOI: 10.1111/j.1600-6143.2007.01893.x]
67. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 2009; 49: 880-886 [PMID: 19101912 DOI: 10.1002/ hep.22686]
68. Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, Alonso EM. Graft histology characteristics in longterm survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582-1587 [PMID: 18975292 DOI: 10.1002/lt.21549]
69. Spada M, Riva S, Maggiore G, Cintorino D, Gridelli B. Pediatric liver transplantation. World J Gastroenterol 2009; 15: 648-674 [PMID: 19222089]
70. Campbell KM, Bucuvalas JC. Renal function in the long term after pediatric liver transplantation: is there a need for protocol kidney biopsies? Curr Opin Organ Transplant 2010; 15: 608-613 [PMID: 20733490 DOI: 10.1097/MOT.0b013e32833da439]
71. Harambat J, Ranchin B, Dubourg L, Liutkus A, Hadj-Haïssa A, Rivet C, Boillot O, Lachaux A, Cochat P. Renal function in pediatric liver transplantation: a long-term follow-up study. Transplantation 2008; 86: 1028-1034 [PMID: 18946339 DOI:10.1097/TP.0b013e318187748f]
72. Bayrakci US, Baskin E, Ozcay F, Gulleroglu K, Ozbay F, Sevmis S, Karakayali H, Haberal M. Abnormal circadian blood pressure regulation in liver transplanted children. Pediatr Transplant 2012; 16: 160-164 [PMID: 22321218 DOI: 10.1111/j.1399-3046.2012.01646.x]
73. McLin VA, Anand R, Daniels SR, Yin W, Alonso EM; SPLIT Research Group. Blood pressure elevation in long-term survivors of pediatric liver transplantation. Am J Transplant 2012; 12:183-190 [PMID: 21992721 DOI: 10.1111/j.1600-6143.2011.03772. x]
74. Gross TG, Hinrichs SH, Winner J, Greiner TC, Kaufman SS, Sammut PH, Langnas AN. Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy. Ann Oncol 1998; 9:339-340 [PMID: 9602271]
75. Gross TG, Orjuela MA, Perkins SL, Park JR, Lynch JC, Cairo MS, Smith LM, Hayashi RJ. Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group Report. Am J Transplant 2012; 12: 3069-3075 [PMID:22883417 DOI: 10.1111/j.1600-6143.2012.04206.x]
76. Kamdar KY, Rooney CM, Heslop HE. Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant 2011; 16: 274-280 [PMID: 21467936 DOI:10.1097/MOT.0b013e3283465715]
77. Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005; 56: 155-167 [PMID: 15979320 DOI: 10.1016/j.critrevo nc.2005.03.015]
78. Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Transplantation 2003; 75:987-993 [PMID: 12698085]
79. Dobbels F, Vanhaecke J, Desmyttere A, Dupont L, Nevens F, De Geest S. Prevalence and correlates of self-reported pretransplant nonadherence with medication in heart, liver, and lung transplant candidates. Transplantation 2005; 79: 1588-1595 [PMID:15940050]
80. Fredericks EM. Nonadherence and the transition to adulthood. Liver Transpl 2009; 15 Suppl 2: S63-S69 [PMID: 19876953 DOI:10.1002/lt.21892]
81. Starzl TE, Iwatsuki S, Klintmalm G, Schröter GP, Weil R, Koep LJ, Porter KA. Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc 1981; 13: 281-285 [PMID: 7022839]
82. Starzl TE, Todo S, Tzakis AG, Gordon RD, Makowka L, Stieber A, Podesta L, Yanaga K, Concepcion W, Iwatsuki S. Liver transplantation: an unfinished product. Transplant Proc 1989; 21:2197-2200 [PMID: 2469232]
83. Ganschow R, Grabhorn E, Burdelski M. Basiliximab in paediatric liver-transplant recipients. Lancet 2001; 357: 388 [PMID: 11211016 DOI: 10.1016/S0140-6736(00)03654-0]
84. Ganschow R, Grabhorn E, Schulz A, Von Hugo A, Rogiers X, Burdelski M. Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients. Pediatr Transplant 2005; 9: 741-745 [PMID: 16269045 DOI: 10.1111/ j.1399-3046.2005.00371.x]
85. Grabhorn E, Schulz A, Helmke K, Hinrichs B, Rogiers X, Broering DC, Burdelski M, Ganschow R. Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation 2004; 78: 235-241 [PMID: 15280684]
86. Heffron TG, Pillen T, Smallwood GA, Welch D, Oakley B, Romero R. Pediatric liver transplantation with daclizumab induction. Transplantation 2003; 75: 2040-2043 [PMID: 12829908 DOI: 10.1097/01.TP.0000065740.69296.DA]
87. Schuller S, Wiederkehr JC, Coelho-Lemos IM, Avilla SG, Schultz C. Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation. Transplant Proc 2005; 37: 1151-1152 [PMID: 15848653 DOI: 10.1016/j.transproceed.2005.01.023]
88. Strassburg CP, Manns MP. [Partial liver transplantation and living donation from the viewpoint of internal medicine]. Der Internist 2002; 43: 1551-1558
89. Di Filippo S. Anti-IL-2 receptor antibody vs. polyclonal antilymphocyte antibody as induction therapy in pediatric transplantation. Pediatr Transplant 2005; 9: 373-380 [PMID: 15910396 DOI:10.1111/j.1399-3046.2005.00303.x]
90. Dell-Olio D, Kelly DA. Calcineurin inhibitor minimization in pediatric liver allograft recipients. Pediatr Transplant 2009; 13:670-681 [PMID: 19413716 DOI: 10.1111/j.1399-3046.2009.01184. x]
91. Tönshoff B, Höcker B. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Pediatr Transplant 2006; 10: 721-729 [PMID:16911497 DOI: 10.1111/j.1399-3046.2006.00577.x]
92. Tredger JM, Brown NW, Dhawan A. Immunosuppression in pediatric solid organ transplantation: opportunities, risks, and management. Pediatr Transplant 2006; 10: 879-892 [PMID:17096754 DOI: 10.1111/j.1399-3046.2006.00604.x]
93. Turmelle YP, Nadler ML, Anderson CD, Doyle MB, Lowell JA, Shepherd RW. Towards minimizing immunosuppression in pediatric liver transplant recipients. Pediatr Transplant 2009; 13:553-559 [PMID: 19067920 DOI: 10.1111/j.1399-3046.2008.01061. x]
94. Evans HM, McKiernan PJ, Kelly DA. Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation. Transplantation 2005; 79: 1575-1580 [PMID: 15940048]
95. Ferraris JR, Duca P, Prigoshin N, Tambutti ML, Boldrini G, Cardoni RL, D'Agostino D. Mycophenolate mofetil and reduced doses of cyclosporine in pediatric liver transplantation with chronic renal dysfunction: changes in the immune responses. Pediatr Transplant 2004; 8: 454-459 [PMID: 15367280 DOI: 10.1111/ j.1399-3046.2004.00172.x]
96. Filler G, Gellermann J, Zimmering M, Mai I. Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity. Transpl Int 2000; 13:201-206 [PMID: 10935703]
97. Hoyer PF, Ettenger R, Kovarik JM, Webb NJ, Lemire J, Mentser M, Mahan J, Loirat C, Niaudet P, VanDamme-Lombaerts R, Offner G, Wehr S, Moeller V, Mayer H. Everolimus in pediatric de nova renal transplant patients. Transplantation 2003; 75: 2082-2085 [PMID: 12829916 DOI: 10.1097/01.TP.0000070139.63068.54]
98. Jiménez-Rivera C, Avitzur Y, Fecteau AH, Jones N, Grant D, Ng VL. Sirolimus for pediatric liver transplant recipients with posttransplant lymphoproliferative disease and hepatoblastoma. Pediatr Transplant 2004; 8: 243-248 [PMID: 15176961 DOI: 10.1111/ j.1399-3046.2004.00156.x]
99. Scheenstra R, Torringa ML, Waalkens HJ, Middelveld EH, Peeters PM, Slooff MJ, Gouw AS, Verkade HJ, Bijleveld CM. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation. Liver Transpl 2006; 12: 240-246 [PMID: 16447209 DOI: 10.1002/lt.20591]
100. Sindhi R, Ganjoo J, McGhee W, Mazariegos G, Reyes J. Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants. Transplant Proc 2002; 34: 1972-1973 [PMID: 12176651]
101. Vester U, Kranz B, Wehr S, Boger R, Hoyer PF; RAD B 351 Study Group. Everolimus (Certican) in combination with neoral in pediatric renal transplant recipients: interim analysis after 3 months. Transplant Proc 2002; 34: 2209-2210 [PMID: 12270366]
102. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, Tchao NK. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012; 307: 283-293 [PMID: 22253395 DOI: 10.1001/jama.2011.2014]
103. Koshiba T, Li Y, Takemura M, Wu Y, Sakaguchi S, Minato N, Wood KJ, Haga H, Ueda M, Uemoto S. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 2007; 17:94-97 [PMID: 17306739 DOI: 10.1016/j.trim.2006.10.004]
104. Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, McMichael J, Fung JJ, Starzl TE. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997; 63: 243-249 [PMID: 9020325]
105. Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol 2007; 17: 114-119 [PMID:17306742 DOI: 10.1016/j.trim.2006.09.033]
106. Starzl TE, Demetris AJ, Trucco M, Ricordi C, Murase N, Thomson AW. The Role of Cell Migration and Chimerism in Organ Transplant Acceptance and Tolerance Induction. Transplant Sci 1993; 3: 47-50 [PMID: 21572595]
107. Takatsuki M, Uemoto S, Inomata Y, Egawa H, Kiuchi T, Fujita S, Hayashi M, Kanematsu T, Tanaka K. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001; 72:449-454 [PMID: 11502975]
108. Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008; 118: 2845-2857 [PMID: 18654667 DOI: 10.1172/JCI35342]
109. Donckier V, Troisi R, Le Moine A, Toungouz M, Ricciardi S, Colle I, Van Vlierberghe H, Craciun L, Libin M, Praet M, Noens L, Stordeur P, Andrien M, Lambermont M, Gelin M, Bourgeois N, Adler M, de Hemptinne B, Goldman M. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl 2006; 12: 1523-1528 [PMID:17004249 DOI: 10.1002/lt.20872]
110. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW, Colvin RB, Sykes M, Sachs DH. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361 [PMID: 18216355 DOI: 10.1056/ NEJMoa071074]
111. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S. Tolerance and chimerism after renal and hematopoieticcell transplantation. N Engl J Med 2008; 358: 362-368 [PMID:18216356 DOI: 10.1056/NEJMoa074191]